Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

The treatment improved acne, seborrhoea, and hirsutism, with some side effects like spotting and nervousness.

Baricitinib was effective in regrowing hair in patients with different levels of alopecia areata severity.

Baricitinib helps regrow hair in severe alopecia areata and is safe, but more research is needed.

JAK inhibitors effectively treat severe alopecia areata with manageable side effects.

Baricitinib helps regrow hair and improves quality of life and mental health in severe alopecia areata patients.

Baricitinib is effective and safe for treating severe alopecia areata for up to 5 years.

Baricitinib improved hair loss and arthritis in a lupus patient.

Baricitinib was effective in regrowing eyebrow and eyelash hair in patients with severe alopecia areata.

Ritlecitinib shows promise for treating alopecia areata with significant hair regrowth and no serious side effects.

Ritlecitinib is effective for treating alopecia areata, showing significant hair regrowth with mild side effects.

Oral baricitinib is effective and safe for treating alopecia areata.

High-dose baricitinib improved severe alopecia areata in most patients without severe side effects.

Baricitinib was effective in treating both early and late onset alopecia areata.

Clascoterone cream is a safer, effective acne treatment with fewer side effects.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Finasteride increased hair count and regrowth in men with hair loss but also caused more sexual side effects than placebo.

Tildrakizumab showed limited effectiveness in treating chronic alopecia areata in a small group of patients.

Baricitinib, a drug for rheumatoid arthritis, atopic dermatitis, and alopecia areata, is generally safe with low risk of major side effects, even in patients with risk factors. It's also effective in promoting hair regrowth in alopecia areata patients.

Baricitinib significantly improved hair regrowth and quality of life in severe alopecia areata patients.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

Apremilast was not effective in treating moderate-to-severe alopecia areata.

The use of Diane-35 and its generics significantly decreased in the Netherlands.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

Ritlecitinib is generally safe for adolescents with alopecia areata over 5 years.

Abrocitinib is being evaluated for safety and effectiveness in treating moderate to severe atopic dermatitis.

Brepocitinib 30mg is most effective for moderate-to-severe alopecia areata, but ritlecitinib 50mg may offer a better balance of safety and effectiveness.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Baricitinib shows promise for treating alopecia areata with mild side effects.